by Richard Daverman, PhD
June 6, 2012 -- ShangPharma and Eli Lilly celebrated ten years of drug development partnership, a relationship that dates back to ShangPharma’s founding in 2002. ShangPharma, a preclinical CRO based in Shanghai’s Zhangjiang Hi-Tech Park, has long had a team exclusively dedicated to working on Lilly projects. In early 2012, ShangPharma opened a new 110,000 square foot facility to house its Lilly-dedicated staff. At the same time, the two companies announced a multi-year extension of their contract. More details....
Stock Symbols: (NYSE: SHP) (NYSE: LLY)
